RESEARCH TRIANGLE PARK, NC--(Marketwire - July 1, 2008) - Pharmaceutical companies are
globalizing their competitive intelligence groups to match the
globalization of brand marketing strategies. A large number of companies
examined in Cutting Edge's new report, "Pharmaceutical Competitive
Intelligence: Expanding the Role and Reach of CI,"
(
www.pharmacompetitiveintelligence.com) have globalized competitive
intelligence functions, enabling them to deliver most impact at the same
place that brand strategies are being set.
Globalizing CI groups also eliminates the issue of CI teams being too far
removed from upper management's ears to affect strategic choices. Global
CI teams' messages have little to no filter before reaching upper
management, preventing dilution of messages.
"Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of
CI," available at
www.pharmacompetitiveintelligence.com, examines CI team
structures, phase-by-phase spending and staffing, and strategies for
improvement. Compiled from surveys and interviews with executives at
leading companies, the report enables CI teams to achieve success.
"By globally aligning their CI teams, companies are placing a greater
emphasis on CI's importance," said David Richardson, lead author of the
report. "CI groups are playing ever more important roles in decisions for
brands, and sitting where key decisions are made increases CI's level of
impact."
Pharmaceutical Competitive Intelligence: Expanding the Role and Reach of CI
focuses on these topics:
-- Structuring for Success -- provides details on CI structures,
including global-level reporting lines and placements; ways in which CI
teams trumpet their successes and create CI cultures; and the career paths
laid out to make CI teams breeding grounds for future pharma leaders
-- Resourcing for Growth -- reveals CI department-level budgets and
staffing; brand-level phase-by-phase spending and staffing; which groups
fund CI; and how companies demonstrate ROI on CI
-- Increasing CI's Reach -- Examines how companies communicate their
strategic value to internal clients and the resources and tools for
collecting CI
The 116-page report examines CI team structures, phase-by-phase spending
and staffing, and strategies for improvement. Compiled from surveys and
interviews with executives at leading companies, the report enables CI
teams to achieve success.
A summary of the report is available for download here:
http://www.cuttingedgeinfo.com/pharmacompetitiveintelligence/PH110_Download.asp#body
Contact Information: CONTACT INFORMATION:
David Richardson
919-433-0216